Nuvectis Pharma Investor Relations Material
Latest events
Q2 2025
5 Aug, 2025
Corporate Presentation
13 Jun, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Nuvectis Pharma Inc
Access all reports
Nuvectis Pharma, Inc. is a biopharmaceutical company specializing in the development of precision medicines aimed at addressing significant unmet medical needs in oncology. The company's development pipeline includes two key clinical-stage drug candidates: NXP800 and NXP900. The company is headquartered in Fort Lee, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Nuvectis Pharma Inc
Corporate Presentation
Nuvectis Pharma Inc
Corporate Presentation
Nuvectis Pharma Inc
Latest articles
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
Ticker symbol
NVCT
Country
🇺🇸 United States